It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2013.
2013 | Hyderabad, Telangana, India | ActiveGale Pharma (India) Private Limited, a active private limited company, was established on 10 May 2013 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51909TG2013PTC087583. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Tipparam Nageshwari (Director), Praveen Kumar Venkata Kottacheruvu (Director), Chilukuri Murali Krishna (Managing Director). Past directors included Sarang Matsendranath Degloorkar, Jayasri Busetty, Santha Bijapuri. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at H.No. 7-39 Bapuji Nagar, Nacharam, Hyderabad, Telangana, 500076.
U51909TG2013PTC087583
087583
10 May 2013
₹5.00 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Gale Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tipparam Nageshwari | Director | 10 May 2013 | Current |
| Praveen Kumar Venkata Kottacheruvu | Director | 26 Jun 2015 | Current |
| Chilukuri Murali Krishna | Managing Director | 18 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2019 | Past |
| Pramod Abcsdd | Director | 28 Oct 2013 | Past |
| Pramod Abcsdd | Director | 10 Jun 2015 | Past |
| Pramod Abcsdd | Director | 22 Feb 2016 | Past |
| Pramod Abcsdd | Managing Director | 22 Feb 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gale Pharma (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 66.9% decrease. The company also saw a substantial fall in profitability, with a 46.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Gale Pharma (India) had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gale Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gale Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gale Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gale Pharma (India) Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
The activity Gale Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was completed.
The activity Chilukuri Murali Krishna was appointed as a Managing Director was appointed as a Managing Director on 18 Feb 2016 & has been associated with this company since 9 years 9 months . was completed.
Praveen Kumar Venkata Kottacheruvu was appointed as a Director was appointed as a Director on 26 Jun 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.
The activity Tipparam Nageshwari was appointed as a Director was appointed as a Director on 10 May 2013 & has been associated with this company since 12 years 6 months . was completed.
Progress on Gale Pharma (India) Private Limited was registered on 10 May 2013 with Roc Hyderabad & aged 12 years 6 months as per MCA records. was documented.
The CIN of Gale Pharma (India) Private Limited is U51909TG2013PTC087583.
Gale Pharma (India) Private Limited is headquartered at H.No. 7-39 Bapuji Nagar, Nacharam, Hyderabad, Telangana, 500076.
Gale Pharma (India) Private Limited was incorporated on 10 May 2013.
The current directors of Gale Pharma (India) Private Limited are
The primary industry of Gale Pharma (India) Private Limited is Manufacturing.
Gale Pharma (India) Private Limited is unlisted.
The authorized capital of Gale Pharma (India) Private Limited is ₹5.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Gale Pharma (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX